• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

HealthcareGlobal Next-Generation Biologics Sales Market Report 2016

  • RnM794399
  • |
  • 8 November, 2016
  • |
  • Global
  • |
  • 101 pages
  • |
  • QYResearch
  • |
  • Healthcare

Notes:
Sales, means the sales volume of Next-Generation Biologics
Revenue, means the sales value of Next-Generation Biologics

This report studies sales (consumption) of Next-Generation Biologics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Next-Generation Biologics in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
Split by applications, this report focuses on sales, market share and growth rate of Next-Generation Biologics in each application, can be divided into
Medical
Scientific Research
Other


Table of Contents

Global Next-Generation Biologics Sales Market Report 2016
1 Next-Generation Biologics Overview
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics
1.2.1 Antibodies
1.2.2 Regenerative medicine
1.2.3 Insulins
1.2.4 Growth hormones
1.2.5 Other
1.3 Application of Next-Generation Biologics
1.3.1 Medical
1.3.2 Scientific Research
1.3.3 Other
1.4 Next-Generation Biologics Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Next-Generation Biologics (2011-2021)
1.5.1 Global Next-Generation Biologics Sales and Growth Rate (2011-2021)
1.5.2 Global Next-Generation Biologics Revenue and Growth Rate (2011-2021)

2 Global Next-Generation Biologics Competition by Manufacturers, Type and Application
2.1 Global Next-Generation Biologics Market Competition by Manufacturers
2.1.1 Global Next-Generation Biologics Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Next-Generation Biologics Revenue and Share by Manufacturers (2011-2016)
2.2 Global Next-Generation Biologics (Volume and Value) by Type
2.2.1 Global Next-Generation Biologics Sales and Market Share by Type (2011-2016)
2.2.2 Global Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
2.3 Global Next-Generation Biologics (Volume and Value) by Regions
2.3.1 Global Next-Generation Biologics Sales and Market Share by Regions (2011-2016)
2.3.2 Global Next-Generation Biologics Revenue and Market Share by Regions (2011-2016)
2.4 Global Next-Generation Biologics (Volume) by Application

3 United States Next-Generation Biologics (Volume, Value and Sales Price)
3.1 United States Next-Generation Biologics Sales and Value (2011-2016)
3.1.1 United States Next-Generation Biologics Sales and Growth Rate (2011-2016)
3.1.2 United States Next-Generation Biologics Revenue and Growth Rate (2011-2016)
3.1.3 United States Next-Generation Biologics Sales Price Trend (2011-2016)
3.2 United States Next-Generation Biologics Sales and Market Share by Manufacturers
3.3 United States Next-Generation Biologics Sales and Market Share by Type
3.4 United States Next-Generation Biologics Sales and Market Share by Application

4 China Next-Generation Biologics (Volume, Value and Sales Price)
4.1 China Next-Generation Biologics Sales and Value (2011-2016)
4.1.1 China Next-Generation Biologics Sales and Growth Rate (2011-2016)
4.1.2 China Next-Generation Biologics Revenue and Growth Rate (2011-2016)
4.1.3 China Next-Generation Biologics Sales Price Trend (2011-2016)
4.2 China Next-Generation Biologics Sales and Market Share by Manufacturers
4.3 China Next-Generation Biologics Sales and Market Share by Type
4.4 China Next-Generation Biologics Sales and Market Share by Application

5 Europe Next-Generation Biologics (Volume, Value and Sales Price)
5.1 Europe Next-Generation Biologics Sales and Value (2011-2016)
5.1.1 Europe Next-Generation Biologics Sales and Growth Rate (2011-2016)
5.1.2 Europe Next-Generation Biologics Revenue and Growth Rate (2011-2016)
5.1.3 Europe Next-Generation Biologics Sales Price Trend (2011-2016)
5.2 Europe Next-Generation Biologics Sales and Market Share by Manufacturers
5.3 Europe Next-Generation Biologics Sales and Market Share by Type
5.4 Europe Next-Generation Biologics Sales and Market Share by Application

6 Japan Next-Generation Biologics (Volume, Value and Sales Price)
6.1 Japan Next-Generation Biologics Sales and Value (2011-2016)
6.1.1 Japan Next-Generation Biologics Sales and Growth Rate (2011-2016)
6.1.2 Japan Next-Generation Biologics Revenue and Growth Rate (2011-2016)
6.1.3 Japan Next-Generation Biologics Sales Price Trend (2011-2016)
6.2 Japan Next-Generation Biologics Sales and Market Share by Manufacturers
6.3 Japan Next-Generation Biologics Sales and Market Share by Type
6.4 Japan Next-Generation Biologics Sales and Market Share by Application

7 Global Next-Generation Biologics Manufacturers Analysis
7.1 Allergan
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Next-Generation Biologics Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 101 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Biogen Idec
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 127 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 Eli Lilly
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Nov Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 Kyowa Hakko Kirin
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Molecular Partners
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Pharma & Healthcare Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.7.4 Main Business/Business Overview
7.8 Pfizer
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.8.4 Main Business/Business Overview
7.9 Roche
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.9.4 Main Business/Business Overview
7.10 Sanofi
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
7.10.4 Main Business/Business Overview

8 Next-Generation Biologics Maufacturing Cost Analysis
8.1 Next-Generation Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Next-Generation Biologics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Next-Generation Biologics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Next-Generation Biologics Market Forecast (2016-2021)
12.1 Global Next-Generation Biologics Sales, Revenue Forecast (2016-2021)
12.2 Global Next-Generation Biologics Sales Forecast by Regions (2016-2021)
12.3 Global Next-Generation Biologics Sales Forecast by Type (2016-2021)
12.4 Global Next-Generation Biologics Sales Forecast by Application (2016-2021)

13 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,000.00
$4,000.00
$8,000.00
2,686.00
2,686.00
5,372.00
3,680.80
3,680.80
7,361.60
484,560.00
484,560.00
969,120.00
265,253.60
265,253.60
530,507.20
Add To Cart Credit card Logo

Related Reports


Reason to Buy